Prescription drug · ANDA
Benzonatate NDC 69452-144
Benzonatate 200 mg/1 · Capsule · Oral · Bionpharma Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 69452-144-20 | 69452014420 | 100 CAPSULE in 1 BOTTLE, PLASTIC (69452-144-20)Marketed from Aug 15, 2016 | |
| 69452-144-30 | 69452014430 | 500 CAPSULE in 1 BOTTLE, PLASTIC (69452-144-30)Marketed from Aug 15, 2016 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Benzonatate
- Generic name (nonproprietary)
- benzonatate
- Active ingredients
- Benzonatate — 200 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Bionpharma Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 081297
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Tracheobronchial Stretch Receptor Activity (Physiologic effect)
- Identifiers
- Product ID 69452-144_54f1a3e7-6d29-ac5e-e063-6394a90ad5b5SPL ID 54f1a3e7-6d29-ac5e-e063-6394a90ad5b5SPL set ID 2630be01-1d2d-4c40-8e56-8568ea89eacfRxCUI 197397, 283417UNII 5P4DHS6ENRUPC 0369452143209
- Pharmacologic class
- Non-narcotic Antitussive
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N469452014420followed by a unit qualifier and the quantityPackage 69452-0144-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE BENZONATATE is indicated for the symptomatic relief of cough.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 081297
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Benzonatate | Benzonatate 200 mg/1 | CapsuleOral | Proficient Rx LP | 71205-605 |
| Benzonatate | Benzonatate 100 mg/1 | CapsuleOral | Coupler LLC | 67046-1484 |
| Benzonatate | Benzonatate 100 mg/1 | CapsuleOral | NuCare Pharmaceuticals,Inc. | 68071-5105 |
| Benzonatate | Benzonatate 100 mg/1 | CapsuleOral | NuCare Pharmaceuticals,Inc. | 68071-5156 |
| Benzonatate | Benzonatate 100 mg/1 | CapsuleOral | Proficient Rx LP | 71205-067 |
| Benzonatate | Benzonatate 200 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-1880 |
| Benzonatate | Benzonatate 100 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-1927 |
| Benzonatate | Benzonatate 200 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 60429-914 |
| Benzonatate | Benzonatate 100 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 60429-927 |
| Benzonatate | Benzonatate 100 mg/1 | CapsuleOral | Bionpharma Inc. | 69452-143 |
| Benzonatate | Benzonatate 100 mg/1 | CapsuleOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-692 |